Skip to content

Ibutilide

Antiarrhythmic — CARDIOVASCULAR SYSTEM

Also known as: ibutilide fumarate, U 82209E, U-82209E, U82209E

OfpFDA approvedATC C01BD05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ibutilide is an ofp drug in the Antiarrhythmic class catalogued in DrugCentral. It was first approved by the FDA in 1995. DrugCentral lists 1 molecular target, including KCNH2. Recorded indications include Cardioversion of Atrial Fibrillation and Cardioversion of Atrial Flutter.

  • Approval status: ofp (first approved 1995 by the FDA).
  • Drug class: Antiarrhythmic.
  • Molecular targets: KCNH2 (1 listed in DrugCentral).
  • Indications: Cardioversion of Atrial Fibrillation and Cardioversion of Atrial Flutter.
  • ATC code: C01BD05 (Antiarrhythmics, class III).
  • Molecular formula: C20H36N2O3S; molecular weight 384.59 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Cardioversion of Atrial Fibrillation
  • Cardioversion of Atrial Flutter

Contraindications (7)

  • Bradycardia
  • Congenital long QT syndrome
  • Heart block
  • Hypokalemia
  • Hypomagnesemia
  • Prolonged QT interval
  • Torsades de pointes

Mechanism & targets

Established pharmacologic classAntiarrhythmic

Molecular targets (1)

TargetGeneActionActivity
Potassium voltage-gated channel subfamily H member 2KCNH2blockerIC50 8.00

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1995-12-28FDA—PHARMACIA AND UPJOHN

ATC classification

ATC codeTherapeutic hierarchy
C01BD05CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › ANTIARRHYTHMICS, CLASS I AND III › Antiarrhythmics, class III

Chemical structure

Molecular formulaC20H36N2O3S
Molecular weight384.59 g/mol
CAS number—
InChIKeyALOBUEHUHMBRLE-UHFFFAOYSA-N
PubChem CID60753
CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ibutilide used for?

DrugCentral lists the following indications for Ibutilide: Cardioversion of Atrial Fibrillation and Cardioversion of Atrial Flutter.

How does Ibutilide work?

Its molecular targets in DrugCentral include KCNH2 (blocker).

When was Ibutilide first approved?

Ibutilide was first approved by the FDA in 1995.

What drug class does Ibutilide belong to?

Ibutilide is in the Antiarrhythmic class.

What is the chemical formula of Ibutilide?

Ibutilide has the molecular formula C20H36N2O3S and a molecular weight of 384.59 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1995-12-28
AgencyFDA
Targets1
Indications2
FormulaC20H36N2O3S
DrugCentral ID1412
Interactive profile